Yosemite ^Investor

Yosemite supports the development of technologies and treatments intended to reduce cancer mortality. The company collaborates with researchers, scientists, and entrepreneurs working across the oncology sector, aiming to accelerate progress in diagnostics, therapies, and care delivery. Yosemite funds projects ranging from early-stage nonprofit initiatives to later-stage companies, providing capital across the full spectrum of cancer innovation. Its investment approach is structured to catalyze breakthroughs that contribute to making cancer a manageable and non-lethal condition. Yosemite's portfolio spans various domains of cancer research and treatment, including targeted therapies, immuno-oncology, early detection, and patient-centric solutions.